Montek LC Dosing in Children
Montek LC (montelukast + levocetirizine) is not dosed per kilogram in children; instead, it uses fixed-dose formulations based on age groups, with children 6-14 years receiving montelukast 5 mg + levocetirizine 5 mg once daily.
Age-Based Dosing for Montelukast Component
The montelukast component of Montek LC follows established FDA-approved dosing 1:
- Ages 6-14 years: 5 mg once daily
- Ages 15 years and older: 10 mg once daily
- Ages 2-5 years: 4 mg once daily (though this age group typically receives montelukast alone, not the combination)
For asthma, administer in the evening; for allergic rhinitis, timing can be individualized 1.
Levocetirizine Component Considerations
While levocetirizine has been studied at weight-based dosing of 0.125 mg/kg twice daily in children 12-24 months 2, 3, the fixed-dose combination product Montek LC uses 5 mg levocetirizine for children 6-14 years, which aligns with standard antihistamine dosing for this age group.
Clinical Evidence for Combination Therapy
The combination of montelukast + levocetirizine demonstrates superior efficacy compared to montelukast monotherapy for allergic rhinitis in children 4:
- Greater reduction in daytime nasal congestion (p=0.0341)
- Greater reduction in daytime rhinorrhea (p=0.0469)
- Greater reduction in nighttime nasal congestion when awake (p=0.0381)
- Improved quality of life (p<0.0001)
- Similar adverse event profile to monotherapy
Recent meta-analyses confirm this combination provides better symptom control than either agent alone, with no increased adverse events 5, 6.
Safety Profile
Montelukast ingestions up to 33.71 mg/kg in children resulted in no serious adverse effects in poison control data 7, suggesting a wide safety margin. However, the FDA has issued a Boxed Warning for montelukast regarding neuropsychiatric events (agitation, depression, suicidal thoughts, sleep disturbances) 1. Reserve this combination for patients with inadequate response to alternative therapies, particularly for allergic rhinitis 1.
Practical Prescribing
For children 6-14 years with allergic rhinitis or asthma:
- Standard dose: One tablet containing montelukast 5 mg + levocetirizine 5 mg once daily
- Timing: Evening administration preferred for asthma; flexible timing for allergic rhinitis
- No weight-based adjustment needed for standard pediatric dosing
- Counsel families about neuropsychiatric symptoms and instruct them to discontinue immediately if behavioral changes occur 1
The combination therapy is particularly useful when nasal congestion and rhinorrhea are prominent symptoms not adequately controlled by monotherapy 4.